Companies: 10,795·Total market cap: $144.5T
Anixa Biosciences, Inc.

Anixa Biosciences, Inc.

ANIXNASDAQHealthcare● Active
$2.46
$-0.02(-0.81%)
Market Cap$82478531
P/E Ratio
52W High$5.46
52W Low$2.44
Overview

Anixa Biosciences, Inc. (ANIX) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

anix · stock forecast · 6 analysts (3M) · FMP · updated Jun 9, 2026

Analyst Rating & Consensus

Based on 6 Wall Street analysts in the past 3 months

SellBuy

Buy

6 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
6
Hold
0
Sell
0
Strong Sell
0
Total: 6 · Buy rate: 100.0%

12-Month Price Target

High

$10.00

Consensus

$5.83

+137.0% upside

Low

$3.50

Median: $4 · Last Close: $2.46

The Anixa Biosciences, Inc. (ANIX) analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month ANIX price target is $5.83, representing +137.0% upside from the current price of $2.46.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $6 (137.0%)

Consensus Target

$5.83

137.0% upside

High Target

$10

306.5%

Low Target

$3.5

42.3%

Current Price

$2.46

as of today

Based on analyst price targets, the ANIX stock price prediction for the next 12 months ranges from $3.5 to $10. The consensus ANIX price forecast of $5.83 implies 137.0% upside from the current price of $2.46.

Short-Term Price Prediction

📅
Earnings Window Active

Short-term predictions are paused during the ±3-day earnings window to avoid unreliable signals.

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$1-50.0%
2028$1-62.5%
2029$1-67.2%
2030$1-69.2%
2031-70.2%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Elevated Volatility — Earnings Window Active (±3 days)· Technical signals still shown. M3 predictions paused.

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)32.1Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · ANIX · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$2.53SELL
MA 10$2.61SELL
MA 20$2.72SELL
MA 50$2.81SELL
MA 100$2.87SELL
MA 200$3.32SELL
Current $ANIX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$2.53SELL
EMA 10$2.60SELL
EMA 20$2.69SELL
EMA 50$2.80SELL
EMA 100$2.94SELL
EMA 200$3.09SELL
Current $ANIX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
D. Boral Capital2026-04-08
Maintains
BuyBuy
D. Boral Capital2026-03-31
Maintains
BuyBuy
D. Boral Capital2026-02-04
Maintains
BuyBuy
D. Boral Capital2025-12-12
Maintains
BuyBuy
D. Boral Capital2025-10-07
Maintains
BuyBuy
D. Boral Capital2025-09-22
Maintains
BuyBuy
HC Wainwright & Co.2025-09-11
Maintains
BuyBuy
D. Boral Capital2025-09-09
Maintains
BuyBuy
D. Boral Capital2025-08-19
Maintains
BuyBuy
D. Boral Capital2025-08-05
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Anixa Biosciences, Inc. (ANIX) stock. Of the recent 40 rating actions, 0 were upgrades and 0 were downgrades. 6 analysts currently cover ANIX.

Analyst Recommendation Trends

Buy ratings312
Hold ratings00
Sell ratings00

ANIX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$0M

Revenue Next Year

$34M

EPS This Year

$-0.34

EPS Next Year

$-0.35

↑ 4.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ANIX EPS of $-0.34 for the current fiscal year, based on estimates from 1 analysts. The ANIX revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The ANIX stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ANIX price target is $5.83 (+137.0% upside), with an analyst consensus of Buy.

The ANIX stock price prediction for 2027 estimates an average of $1. The ANIX stock prediction for 2030 projects a range of $1–$1.

Anixa Biosciences, Inc. trades on NASDAQ under the ticker ANIX. The ANIX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

ANIX forecast · 8 questions

According to 6 Wall Street analysts, the average 12-month ANIX price target is $5.83, with a high forecast of $10.00 and a low of $3.50. The median price target is shown in the chart above when available. This implies +137.0% potential upside from the current price of $2.46.

ANIX price targetWhat is ANIX price targetANIX analyst price targetANIX 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.